Safety and Efficacy of Basiliximab in Calcineurin Inhibitor Intolerant Long-term Kidney Transplant Recipients Treated With Mycophenolic Acid and Steroids

NCT00284947 · clinicaltrials.gov ↗

PHASE4

Phase

COMPLETED

Status

7

Enrollment

INDUSTRY

Sponsor class

Conditions

Kidney Transplantation
Adverse Effects

Interventions

DRUG: basiliximab
DRUG: MMF/EC-MPS
DRUG: Corticosteroids

Sponsor

Novartis